Pilot Study of Maternal Autoantibody-Related Autism.
Pilot Study of Maternal Autoantibody-Related Autism.
复制标题
DOI:
10.1097/dbp.0000000000001100
复制
发表时间:
2022-10-01
影响因子:
2.4
通讯作者:
Van de Water, Judy
中科院分区:
文献类型:
--
作者:
Angkustsiri, Kathleen;Fussell, Jill J.;Bennett, Amanda;Schauer, Joseph;Ramirez-Celis, Alexandra;Hansen, Robin L.;Van de Water, Judy
关键词:
To investigate the presence of Maternal Autoantibody-Related Autism Spectrum Disorder (MAR ASD) in 2 geographically distinct DBPNet clinical sites (Pennsylvania and Arkansas). MAR ASD is a biologically defined subtype of autism spectrum disorder that is defined by the presence of autoantibodies specific to proteins in the fetal brain and present in approximately 20% of a Northern California sample but has not been studied in other states. Sixty-eight mothers of children with ASD were recruited from 2 DBPNet clinics and provided blood samples. Mothers also completed behavioral questionnaires about their children, and data from the child’s clinical diagnostic assessment was abstracted. Mean age of mothers was 38.5±6.1 years, and mean age of children was 8.3±2.7 years. MAR ASD was present in 24% of the sample and similar across sites. Children of +MAR mothers had more severe autism symptoms as measured by ADOS comparison scores (W=3604, p<0.001) and the Social Communication Questionnaire (W=4556; p<0.001). There were no differences in IQ, adaptive function, or aberrant behavior. MAR ASD is a subtype of autism that is present in similar frequencies across 3 states and related to autism severity.